Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.

AIDS (London, England) - 31 May 2007

Seyler Catherine, Adjé-Touré Christiane, Messou Eugène, Dakoury-Dogbo Nicole, Rouet François, Gabillard Delphine, Nolan Monica, Toure Siaka, Anglaret Xavier

Abstract excerpt

OBJECTIVES: To analyse the association between the presence of resistance mutations and treatment outcomes. The impact of HIV-1 drug resistance mutations in African adults on HAART has so far never been reported. METHODS: In 2004 in Abidjan, Côte d'Ivoire, 106 adults on HAART had plasma viral load measurements. Patients with detectable viral loads had resistance genotypic tests. Patients were followed until 2006....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cote d'Ivoire

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 17502726
DOI: 10.1097/QAD.0b013e3281c615da
PMCID: PMC2486349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.PMID 17502726Read ↗

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.Semantic proximity Read ↗

The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.Semantic proximity Read ↗

Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.Semantic proximity Read ↗

Impact of pre-existing drug resistance on risk of virological failure in South Africa.Semantic proximity Read ↗

Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.Semantic proximity Read ↗

HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.Semantic proximity Read ↗

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.Semantic proximity Read ↗

High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.Semantic proximity Read ↗

Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.Semantic proximity Read ↗

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patientsSemantic proximity Read ↗

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.